JYNARQUE
@jynarque.com
JYNARQUE® is proven to slow kidney decline in adults at risk for rapidly progressing ADPKD. See FULL PRESCRIBING INFORMATION, including BOXED WARNING and MEDICATION GUIDE.
JYNARQUE's Company Logos
JYNARQUE's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#575B5C
Abbey
87, 91, 92
192, 3, 35
5, 1, 0, 64
#A8B8D7
Pigeon Post
168, 184, 215
220, 37, 75
22, 14, 0, 16
#3C3C3C
Mine Shaft
60, 60, 60
0, 0, 24
0, 0, 0, 76
About JYNARQUE
JYNARQUE® is a renowned brand offering tablets of tolvaptan that have been clinically proven to slow down kidney function decline in adults who are at risk of rapidly progressing ADPKD (autosomal dominant polycystic kidney disease). The brand emphasizes the importance of understanding and managing ADPKD progression, offering valuable resources, including patient stories and a supportive community, to aid individuals in their journey. JYNARQUE® is the sole FDA-approved treatment for adults with rapidly progressing ADPKD, showcasing long-term efficacy in preserving kidney function.
The brand prioritizes patient well-being by providing copay assistance to eligible individuals, ensuring affordability and accessibility. Notably, JYNARQUE® has a comprehensive REMS program to mitigate risks such as serious liver problems, highlighting the brand's commitment to safety and patient welfare. Explore the possibilities with JYNARQUE® and take proactive steps to combat ADPKD progression
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
